• On February 10, 2020, the legislature enacted HB 703 relative to new high-cost prescription drugs. The law requires a prescription drug manufacturer to notify the Insurance Department “if it is introducing a new prescription drug to market at a wholesale acquisition cost that exceeds the threshold set for a specialty drug under the Medicare Part D program.” RSA 318:68, I.
• Bulletin: HB 703, New High-Prescription Drugs

Information must be submitted to the Department using the following template:

• High-Cost Prescription Drug File Template